Table 1 Characteristics and Comparison of the two population study

Gender

0.034

   Male

469 (80.4%)

190 (74%)

   Female

114 (19.6%)

67 (26%)

Age

0.220

   ≤ 65

484 (83%)

222 (86.4%)

   >65

99 (17%)

35 (13.6%)

Diabetes Mellitus

0.280

   No

493 (84.7%)

225 (87.5%)

   Yes

89 (15.3%)

32 (12.5%)

End-stage renal disease

0.360

   No

567 (97.4%)

253 (98.4%)

   Yes

15 (2.6%)

4 (1.6%)

Smoking

0.256

   No

317 (58.6%)

151 (62.9%)

   Yes

224 (41.4%)

89 (37.1%)

Alcohol

0.088

   No

318 (64.8%)

152 (71.4%)

   Yes

173 (35.2%)

61 (28.6%)

HbsAg

0.546

   (-)

168 (30.9%)

80 (33.1%)

   (+)

376 (69.1%)

162 (66.9%)

Anti-HCV

0.492

   (-)

263 (57.7%)

133 (60.5%)

   (+)

193 (42.3%)

87 (39.5%)

AST

<0.001

   ≤ 34

201 (35.6%)

123 (50.4%)

   >34

363 (64.4%)

121 (49.6%)

ALT

<0.001

   ≤ 36

192 (35.2%)

123 (50%)

   >36

354 (64.8%)

123 (50%)

ALK-P

0.001

   ≤ 94

364 (68.2%)

186 (80.2%)

   >94

170 (31.8%)

46 (19.8%)

Albumin

<0.001

   ≤ 3.5

100 (18.6%)

13 (5.5%)

   >3.5

439 (81.4%)

222 (94.5%)

AFP

0.002

   ≤ 15

123 (24.6%)

112 (44.8%)

   >15

378 (75.4%)

138 (55.2%)

Bilirubin Total

0.373

   ≤ 1.3

480 (83.9%)

221 (86.3%)

   >1.3

92 (16.1%)

35 (13.7%)

Bun

0.482

   ≤ 21

463 (86.2%)

200 (88.12%)

   >21

74 (13.8%)

27 (11.9%)

PT INR

0.146

   ≤ 1.5

389 (97.5%)

160 (99.4%)

   >1.5

10 (2.5%)

1 (0.6%)

Child stage

0.031

A

528 (91.7%)

247 (96.5%)

B

44 (7.6%)

9 (3.5%)

C

4 (0.7%)

0 (0%)

Complication

0.04

No

459 (78.7%)

218 (84.8%)

Yes

124 (21.3%)

39 (15.2%)

Pathology factor

Capsule

0.836

No

150 (28.1%)

69 (28.9%)

Yes

383 (71.9%)

170 (71.1%)

Daughter Nodules

0.071

No

426 (87.5%)

208 (90.4%)

Yes

61 (12.5%)

22 (9.6%)

Cirrhosis

0.007

No

188 (33.3%)

108 (43%)

Yes

377 (66.7%)

143 (57%)

Tumor size

0.013

   ≤ 5 cm

471 (82.3%)

228 (88.7%)

   >5 cm

104 (17.7%)

29 (11.3%)